World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
115
Citations
61383
World Ranking
389
National Ranking
35

Medicine

D-Index
115
Citations
61598
World Ranking
4467
National Ranking
440

Overview

Andrew J. Pollard is affiliated with the University of Oxford in the United Kingdom. Their research primarily spans the field of Medicine, with a significant focus on Infectious Diseases, Epidemiology, Health, Immunology, and Food Science as subfields of study.

Pollard's work covers various main topics including:

  • SARS-CoV-2 and COVID-19 Research
  • Respiratory viral infections research
  • Viral gastroenteritis research and epidemiology
  • Vaccine Coverage and Hesitancy
  • COVID-19 Clinical Research Studies
  • Pneumonia and Respiratory Infections
  • Salmonella and Campylobacter epidemiology

Recent papers authored or co-authored by Pollard include:

  • "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK" (2020), published in The Lancet
  • "Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial" (2020), published in The Lancet
  • "A guide to vaccinology: from basic principles to new developments" (2020), published in Nature Reviews. Immunology
  • "Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant" (2021), published in New England Journal of Medicine
  • "Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment" (2021), published in The Lancet

Pollard frequently collaborates with several co-authors, including:

  • Federico Martinón-Torres
  • Teresa Lambe
  • Peter Openshaw
  • Harish Nair
  • Sagida Bibi

Their research has been published in numerous venues, with recurring publications in:

  • The Journal of Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Lancet
  • Vaccine
  • SSRN Electronic Journal

Best Publications

  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

    M Voysey;Clemens Sac.;S A Madhi;L Y Weckx

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

    P M Folegatti;K J Ewer;P K Aley;B Angus

  • A guide to vaccinology: from basic principles to new developments

    Andrew J. Pollard;Else M. Bijker

  • Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

    M Voysey;S A Costa Clemens;S A Madhi;L Y Weckx

  • Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.

    Olivier J Wouters;Kenneth C Shadlen;Maximilian Salcher-Konrad;Andrew J Pollard

  • Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum

    Unknown

  • Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.

    S. A. Madhi;V. Baillie;C. L. Cutland;M. Voysey

  • Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

    M N Ramasamy;A M Minassian;K J Ewer;A L Flaxman

  • Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.

    Shuo Feng;Daniel J. Phillips;Thomas White;Homesh Sayal

  • Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.

    D Zhou;W Dejnirattisai;P Supasa;C Liu

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

    Pedro M Folegatti;Katie J Ewer;Parvinder K Aley;Brian Angus

  • COVID-19 Vaccine Hesitancy in the UK: The Oxford Coronavirus Explanations, Attitudes, and Narratives Survey (OCEANS) II.

    Daniel Freeman;Daniel Freeman;Bao S. Loe;Andrew Chadwick;Cristian Vaccari

  • Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

    Unknown

  • Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.

    C Liu;H M Ginn;W Dejnirattisai;P Supasa

  • What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2.

    Susanne H Hodgson;Kushal Mansatta;Garry Mallett;Victoria Harris

  • Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.

    Katherine R W Emary;Tanya Golubchik;Parvinder K Aley;Cristina V Ariani

  • T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

    K J Ewer;Barrett;S Belij-Rammerstorfer;H Sharpe

  • Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

    Andrew J. Pollard;Kirsten P. Perrett;Peter C. Beverley

  • Antibody evasion by the P.1 strain of SARS-CoV-2.

    W Dejnirattisai;D Zhou;P Supasa;C Liu

  • Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.

    P Supasa;D Zhou;W Dejnirattisai;C Liu

  • A CD8 + T cell transcription signature predicts prognosis in autoimmune disease

    Eoin F McKinney;Paul A Lyons;Edward J Carr;Jane L Hollis

  • Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine (preprint)

    Voysey, Merryn, Costa Clemens, Sue Ann, Madhi, Shabir A.;Weckx, Lily Yin, Folegatti, Pedro M.;Parvinder K. Aley;Angus, Brian John, Baillie, Vicky, Barnabas, Shaun L.

Frequent Co-Authors

Matthew D. Snape
Matthew D. Snape University of Oxford
Adam Finn
Adam Finn University of Bristol
Paul T. Heath
Paul T. Heath St George's, University of London
Saul N. Faust
Saul N. Faust University Hospital Southampton NHS Foundation Trust
Daniel T. O'Connor
Daniel T. O'Connor University of California, San Diego
Teresa Lambe
Teresa Lambe University of Oxford
Michael Levin
Michael Levin Tufts University
Gordon Dougan
Gordon Dougan University of Cambridge
Sarah C. Gilbert
Sarah C. Gilbert University of Oxford
Paul Klenerman
Paul Klenerman University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying immunology in the USA, expanding into healthcare roles can open diverse career opportunities. Many professionals consider advancing their education by exploring specialized online programs, such as the top psychiatric mental health nurse practitioner programs online. These programs offer flexibility and strong clinical placement rates, ideal for working students aiming to enhance their credentials in mental health settings.

Cost is also a significant factor when pursuing further education. Students should explore the cheapest pmhnp programs to find quality education that fits their budget without compromising on clinical experience and certification readiness.

Understanding financial outcomes post-graduation is crucial. The dnp salary information highlights how salaries can vary regionally, helping graduates make informed decisions on where to work or specialize. This data is especially useful for those who hold a Doctor of Nursing Practice degree and are assessing return on investment.

Additionally, transitions within nursing specialties, like moving from family nurse practitioner roles, are common. Guidance on acute care certification for fnp enables nurses to broaden their expertise and take on acute care responsibilities—skills that complement immunology knowledge in clinical practice.

Best Scientists Citing Andrew J. Pollard

Trending Scientists